in JIA Although tumor necrosis factor inhibitors (TNFi) are the most commonly used bDMARDs in children Risk factors for poor prognosis and disease activity measures Consideration of risk factors for poor outcome (e.g., involvement of ankle, wrist, hip, sacroiliac joint, and/or TMJ, presence of erosive disease or enthesitis, delay in diagnosis, elevated levels of inflammation markers, symmetric disease) is conditionally recommended to guide treatment decisions. Use of validated disease activity